Table 1.
Summary of Patients’ (n=228) Demographics, Comorbiditiesa, Stroke Characteristics, Treatments, and Outcomes
| Characteristics | Value, n (%)b |
|---|---|
| Age, mean (SD), y | 65.8 (14.3) |
| Male sex | 104 (45.6) |
| Comorbidities | |
| Hypertension | 166 (72.8) |
| Hyperlipidemia | 104 (45.6) |
| Diabetes mellitus | 67 (29.4) |
| Recentc or active smoker | 50 (21.9) |
| Atrial fibrillation | 77 (33.8) |
| Antiplatelet drug use | 73 (32.0) |
| Anticoagulant use | 51 (22.4) |
| Stroke characteristics | |
| NIH stroke scale, mean (SD) | 16.3 (7.1) |
| ICA occlusion | 67 (29.4) |
| M1 occlusion | 131 (57.5) |
| M2 occlusion | 27 (11.8) |
| A1 occlusion | 3 (1.3) |
| Left circulation | 111 (48.7) |
| Stroke treatment | |
| IV thrombolysis | 119 (52.2) |
| Time to groin puncture, median (IQR), min | 260 (180, 375.8) |
| mTICI 0 | 9 (3.9) |
| mTICI 1 | 19 (8.3) |
| mTICI 2a | 17 (7.5) |
| mTICI 2b | 76 (33.3) |
| mTICI 3 | 107 (46.9) |
| Antihypertensive IV drip use | 56 (24.6) |
| Vasopressor IV drip use | 32 (14.0) |
| Outcomes | |
| No hemorrhage | 165 (72.4) |
| Asymptomatic hemorrhage | 50 (21.9) |
| Symptomatic hemorrhage | 13 (5.7) |
| mRS 0 | 27 (14.2) |
| mRS 1 | 21 (11.1) |
| mRS 2 | 23 (12.1) |
| mRS 3 | 24 (12.6) |
| mRS 4 | 29 (15.3) |
| mRS 5 | 12 (6.3) |
| mRS 6 | 54 (28.4) |
| Unknown | 38 (16.7) |
A1 indicates proximal segment of anterior cerebral artery; ICA, internal carotid artery; IQR, interquartile range; IV, intravenous; M1 and M2, proximal segments of middle cerebral artery; mRS, modified Rankin Scale; mTICI, modified Treatment in Cerebral Infarction score; NIH, National Institutes of Health.
a
Known at the time of stroke admission.
b
Values are reported as total number and percent, n (%), unless otherwise specified in the characteristic description.
c
Less than a month.